C4X Discovery Sells Substance Use Treatment Rights to Indivior for GBP16 Mln

By Elena Vardon C4X Discovery Holdings on Tuesday said it is selling the proprietary rights to its oral Orexin-1 receptor antagonist for substance use...

Related Keywords

London ,City Of ,United Kingdom ,Elena Vardon ,Bhavna Hunjan ,X Discovery Holdings On ,Astrazeneca ,Discovery Holdings ,Business Officer Bhavna Hunjan ,Article Normal ,Pharmaceuticals ,Healthcare Life Sciences ,Specialized Drugs Medications ,Drug Substance Use Abuse ,Political General News ,Society Community ,Social Issues ,Synd ,C4x Discovery Holdings ,C4xd Ln ,Uk C4xd ,Indivior ,Indv Ln ,Uk Indv ,Drug ,Substance Use ,Abuse ,Political ,General News ,Society ,Community ,Healthcare ,Life Sciences ,Specialized Drugs ,Medications ,